Annual FCF
-$68.79 M
-$25.82 M-60.08%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual free cash flow is -$68.79 million, with the most recent change of -$25.82 million (-60.08%) on September 30, 2024.
- During the last 3 years, OTLK annual FCF has fallen by -$14.54 million (-26.80%).
- OTLK annual FCF is now -632.85% below its all-time high of -$9.39 million, reached on September 30, 2014.
Performance
OTLK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$16.98 M
+$2.53 M+12.97%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly free cash flow is -$16.98 million, with the most recent change of +$2.53 million (+12.97%) on September 1, 2024.
- Over the past year, OTLK quarterly FCF has dropped by -$3.95 million (-30.31%).
- OTLK quarterly FCF is now -30479.07% below its all-time high of $55.90 thousand, reached on September 30, 2017.
Performance
OTLK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$68.79 M
-$4.24 M-6.57%
September 1, 2024
Summary
- As of February 7, 2025, OTLK TTM free cash flow is -$68.79 million, with the most recent change of -$4.24 million (-6.57%) on September 1, 2024.
- Over the past year, OTLK TTM FCF has dropped by -$21.69 million (-46.05%).
- OTLK TTM FCF is now -1540.18% below its all-time high of -$4.19 million, reached on December 31, 2014.
Performance
OTLK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
OTLK Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.1% | -30.3% | -46.0% |
| 3 y3 years | -26.8% | -88.9% | -26.8% |
| 5 y5 years | -110.2% | -139.8% | -128.1% |
OTLK Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.1% | at low | -109.3% | +19.5% | -69.9% | at low |
| 5 y | 5-year | -116.4% | at low | -185.2% | +19.5% | -168.2% | at low |
| alltime | all time | -632.9% | at low | <-9999.0% | +19.5% | -1540.2% | at low |
Outlook Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$68.79 M(+60.1%) | - | - |
| Sep 2024 | - | -$16.98 M(-13.0%) | -$68.79 M(+6.6%) |
| Jun 2024 | - | -$19.51 M(+1.3%) | -$64.55 M(+10.8%) |
| Mar 2024 | - | -$19.27 M(+47.8%) | -$58.26 M(+23.7%) |
| Dec 2023 | - | -$13.03 M(+2.3%) | -$47.10 M(+9.6%) |
| Sep 2023 | -$42.97 M(-24.2%) | -$12.74 M(-3.6%) | -$42.97 M(+6.2%) |
| Jun 2023 | - | -$13.22 M(+62.9%) | -$40.48 M(-16.3%) |
| Mar 2023 | - | -$8.11 M(-8.8%) | -$48.37 M(-11.4%) |
| Dec 2022 | - | -$8.90 M(-13.2%) | -$54.59 M(-3.7%) |
| Sep 2022 | -$56.67 M(+4.5%) | -$10.25 M(-51.4%) | -$56.67 M(+2.3%) |
| Jun 2022 | - | -$21.10 M(+47.2%) | -$55.41 M(+1.7%) |
| Mar 2022 | - | -$14.33 M(+30.4%) | -$54.51 M(+5.0%) |
| Dec 2021 | - | -$10.99 M(+22.2%) | -$51.92 M(-4.3%) |
| Sep 2021 | -$54.25 M(+70.7%) | -$8.99 M(-55.5%) | -$54.25 M(-5.4%) |
| Jun 2021 | - | -$20.19 M(+71.9%) | -$57.34 M(+33.0%) |
| Mar 2021 | - | -$11.75 M(-11.8%) | -$43.10 M(+12.1%) |
| Dec 2020 | - | -$13.32 M(+10.3%) | -$38.44 M(+20.9%) |
| Sep 2020 | -$31.79 M(-2.9%) | -$12.08 M(+102.8%) | -$31.79 M(+23.9%) |
| Jun 2020 | - | -$5.96 M(-15.9%) | -$25.65 M(-14.9%) |
| Mar 2020 | - | -$7.08 M(+6.1%) | -$30.16 M(+2.6%) |
| Dec 2019 | - | -$6.67 M(+12.3%) | -$29.38 M(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | -$32.73 M(-8.6%) | -$5.94 M(-43.2%) | -$32.73 M(-10.2%) |
| Jun 2019 | - | -$10.46 M(+65.7%) | -$36.44 M(+5.1%) |
| Mar 2019 | - | -$6.31 M(-37.0%) | -$34.69 M(-3.9%) |
| Dec 2018 | - | -$10.02 M(+3.7%) | -$36.09 M(+0.8%) |
| Sep 2018 | -$35.82 M(+126.8%) | -$9.66 M(+11.0%) | -$35.82 M(+37.2%) |
| Jun 2018 | - | -$8.70 M(+12.8%) | -$26.11 M(+13.0%) |
| Mar 2018 | - | -$7.71 M(-20.9%) | -$23.11 M(+18.2%) |
| Dec 2017 | - | -$9.75 M(<-9900.0%) | -$19.55 M(+23.8%) |
| Sep 2017 | -$15.80 M(-66.1%) | $55.90 K(-101.0%) | -$15.80 M(-40.5%) |
| Jun 2017 | - | -$5.71 M(+37.4%) | -$26.55 M(-28.9%) |
| Mar 2017 | - | -$4.15 M(-30.7%) | -$37.34 M(-7.1%) |
| Dec 2016 | - | -$5.99 M(-44.0%) | -$40.19 M(-13.7%) |
| Sep 2016 | -$46.58 M(+28.4%) | -$10.70 M(-35.1%) | -$46.58 M(-7.2%) |
| Jun 2016 | - | -$16.49 M(+135.3%) | -$50.19 M(+6.3%) |
| Mar 2016 | - | -$7.01 M(-43.3%) | -$47.22 M(+6.2%) |
| Dec 2015 | - | -$12.38 M(-13.5%) | -$44.46 M(+22.6%) |
| Sep 2015 | -$36.28 M(+286.5%) | -$14.31 M(+5.8%) | -$36.28 M(+65.1%) |
| Jun 2015 | - | -$13.53 M(+218.0%) | -$21.97 M(+160.1%) |
| Mar 2015 | - | -$4.25 M(+1.4%) | -$8.45 M(+101.4%) |
| Dec 2014 | - | -$4.19 M | -$4.19 M |
| Sep 2014 | -$9.39 M | - | - |
FAQ
- What is Outlook Therapeutics annual free cash flow?
- What is the all time high annual FCF for Outlook Therapeutics?
- What is Outlook Therapeutics annual FCF year-on-year change?
- What is Outlook Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly FCF year-on-year change?
- What is Outlook Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Outlook Therapeutics?
- What is Outlook Therapeutics TTM FCF year-on-year change?
What is Outlook Therapeutics annual free cash flow?
The current annual FCF of OTLK is -$68.79 M
What is the all time high annual FCF for Outlook Therapeutics?
Outlook Therapeutics all-time high annual free cash flow is -$9.39 M
What is Outlook Therapeutics annual FCF year-on-year change?
Over the past year, OTLK annual free cash flow has changed by -$25.82 M (-60.08%)
What is Outlook Therapeutics quarterly free cash flow?
The current quarterly FCF of OTLK is -$16.98 M
What is the all time high quarterly FCF for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly free cash flow is $55.90 K
What is Outlook Therapeutics quarterly FCF year-on-year change?
Over the past year, OTLK quarterly free cash flow has changed by -$3.95 M (-30.31%)
What is Outlook Therapeutics TTM free cash flow?
The current TTM FCF of OTLK is -$68.79 M
What is the all time high TTM FCF for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM free cash flow is -$4.19 M
What is Outlook Therapeutics TTM FCF year-on-year change?
Over the past year, OTLK TTM free cash flow has changed by -$21.69 M (-46.05%)